<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It is proposed that <z:e sem="disease" ids="C0024291" disease_type="Disease or Syndrome" abbrv="">hemophagocytic lymphohistiocytosis</z:e> (HLH) and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) may be temporally distinct phases of pathophysiologically related disease processes </plain></SENT>
<SENT sid="1" pm="."><plain>A significant subgroup of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> may develop from subclinical HLH </plain></SENT>
<SENT sid="2" pm="."><plain>In that case, HLH-like disease would chronically proceed with <z:e sem="disease" ids="C0023882" disease_type="Disease or Syndrome" abbrv="">little disease</z:e> activity or under occasional flares only, until it first becomes clinically apparent at the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> stage </plain></SENT>
<SENT sid="3" pm="."><plain>At the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> stage, however, HLH activity may be easily overlooked by histological or cytogenetic means, since <z:e sem="disease" ids="C0876991" disease_type="Disease or Syndrome" abbrv="">hemophagocytosis</z:e> has fallen already largely silent </plain></SENT>
<SENT sid="4" pm="."><plain>Current treatment options for HLH, like high-dose intravenous immunoglobulins (IVIG), may turn out to be helpful in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients as well </plain></SENT>
<SENT sid="5" pm="."><plain>In rare and extreme cases, Leptospira <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> causes severe and life-threatening HLH </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, this proposal also implies that an insufficient, dysfunctional or misdirected immunological response to Leptospira <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> may lead to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in the long run in a significant number of cases, which have not been recognized as Leptospira -triggered events in the first place </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">Infections</z:e> by agents other than Leptospira may lead to subclinical HLH-like disease with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> as a late stage as well </plain></SENT>
</text></document>